Corning Clinical Laboratories to use AutoPap system:
This article was originally published in Clinica
Corning Clinical Laboratories is to use NeoPath's recently approved AutoPap 300 QC system as part of its quality control for rescreening Pap smears in its 25 testing facilities in the US. The first instruments are expected to be operating at the company's Chicago facility in January 1996. The agreement with Corning follows an earlier decision by SmithKline Beecham to use AutoPap in its clinical laboratories (see Clinica No 675, p 16).
You may also be interested in...
New guidance from the UK regulator covers distribution and deployment of Pfizer/BioNTech's COVID-19 vaccine, which will be complex because of the temperature storage requirements and the large packs in which the vaccine doses will be delivered.
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Alpha Source hired a new CEO from Mayline, while Mölnlycke’s CEO comes from CellaVision; Xvivo Perfusion finance chief changed job to become chief operating officer; Shire senior VP now COO at AVITA; and more.